DRG | Description | Total Hospitalizations (Oct 2016 to Sep 2019) | % of DRG Group | State % of DRG Group | The difference from State Benchmark | National % of DRG Group | The difference from National Benchmark |
---|---|---|---|---|---|---|---|
DRG Group | Aftercare | 93 | |||||
949 | AFTERCARE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | 82 | |||||
950 | AFTERCARE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | 11 | |||||
DRG Group | Aftercare, Musculoskeletal System and Connective Tissue | 80 | |||||
560 | AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH COMPLICATION OR COMORBIDITY (CC) | 38 | |||||
561 | AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | 24 | |||||
559 | AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | 18 | |||||
DRG Group | Degenerative Nervous System Disorders | 64 | |||||
057 | DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | 46 | |||||
056 | DEGENERATIVE NERVOUS SYSTEM DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | 18 | |||||
DRG Group | Signs and Symptoms | 22 | |||||
948 | SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | 15 |